BIOLOGIC RESPONSE-MODIFYING AGENTS - WHAT IS AN APPROPRIATE PHASE-I-II STRATEGY

被引:0
|
作者
CARTER, SK
机构
[1] STANFORD UNIV,STANFORD,CA 94305
[2] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [21] PHASE-I-II STUDY OF FLUTAMIDE IN METASTATIC BREAST-CANCER
    PERRAULT, DJ
    LOGAN, D
    BRAMWELL, V
    EISENHAUER, E
    PRITCHARD, K
    STEWART, D
    WHITE, D
    BREAST CANCER RESEARCH AND TREATMENT, 1986, 8 (01) : 90 - 90
  • [22] SAFETY AND TOLERANCE OF NAVELBINE IN PHASE-I-II CLINICAL-STUDIES
    BESENVAL, M
    DELGADO, M
    DEMAREZ, JP
    KRIKORIAN, A
    SEMINARS IN ONCOLOGY, 1989, 16 (02) : 37 - 40
  • [23] What I should do before considering biologic agents
    Willermain, F.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [24] PHASE-I-II EVALUATION OF CARMINOMYCIN IN ADULTS WITH ACUTE-LEUKEMIA
    DEBUSSCHER, L
    MALARME, M
    BRON, D
    ROZENCWEIG, M
    STRYCKMANS, P
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (01): : 31 - 34
  • [25] PHASE-I-II EVALUATION OF ACRONINE IN PATIENTS WITH MULTIPLE-MYELOMA
    SCARFFE, JH
    BEAUMONT, AR
    CROWTHER, D
    CANCER TREATMENT REPORTS, 1983, 67 (01): : 93 - 94
  • [26] A PHASE-I-II TRIAL OF CONTINUOUS INFUSION VP16-213
    VANECHO, DA
    AISNER, J
    WHITACRE, M
    WIERNIK, PH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 237 - 238
  • [27] PHASE-I-II STUDY OF HEXAMETHYLMELAMINE PLUS DIBROMODULCITOL IN REFRACTORY CARCINOMA OF THE BREAST
    VANAMBURG, AL
    PRESANT, CA
    VELEZGARCIA, E
    KLAHR, C
    CANCER TREATMENT REPORTS, 1979, 63 (01): : 141 - 142
  • [28] PHASE-I-II STUDY OF DIHYDROXYANTHRACENEDIONE (DHAD) IN ACUTE-LEUKEMIA (AL)
    ESTEY, EH
    KEATING, MJ
    MCCREDIE, KB
    BODEY, GP
    FREIREICH, EJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 490 - 490
  • [29] PHASE-I-II TRIAL OF ERYTHROPOIETIN IN THE TREATMENT OF CISPLATIN-ASSOCIATED ANEMIA
    MILLER, CB
    PLATANIAS, LC
    MILLS, SR
    ZAHURAK, ML
    RATAIN, MJ
    ETTINGER, DS
    JONES, RJ
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (02) : 98 - 103
  • [30] PHASE-I-II TRIAL OF DEOXYCOFORMYCIN (DCF) IN T-CELL MALIGNANCIES
    KUFE, D
    MAJOR, P
    AGARWAL, R
    REINHERZ, E
    FREI, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 328 - 328